大容量非経口薬（LVP）の世界市場レポート 2025年

大容量非経口薬（LVP）市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.4％で194億6,000万米ドルに成長します。予測期間の成長は、生物製剤とバイオシミラーの需要拡大、ヘルスケア支出の増加、医薬品アウトソーシングの拡大、個別化医療への注目の高まり、医薬品サプライチェーンの世界化などに起因すると考えられます。予測期間における主な動向としては、製造プロセスの技術的進歩、医薬品製造における先端技術の統合、シングルユース技術の導入、高濃度製剤の開発、医薬品向け3dプリンティングアプリケーションの増加などが挙げられます。

慢性疾患の有病率の増加は、今後数年間の大容量非経口薬市場の成長を促進すると予想されます。慢性疾患とは、通常3カ月以上持続し、時間の経過とともに悪化する病気や状態を指します。慢性疾患の増加は、タバコの使用、副流煙への暴露、栄養不良などの要因によるところが大きいです。慢性疾患の患者は、体力を維持するために必須栄養素の正確なバランスを必要とすることが多く、非経口投与では、薬剤の大部分が消化器系をバイパスして循環系に直接吸収されるため、医薬品の投与量を正確に送達することができます。例えば、2023年9月、スイスに本部を置く国連の専門機関である世界保健機関（WHO）は、全世界の年間死亡者数が4,100万人で、非感染性疾患（NCDs）または慢性疾患による死亡者数の74％を占めると報告しました。したがって、慢性疾患の有病率の増加が大容量非経口薬市場の拡大を後押ししています。

ヘルスケア支出の増加は、今後の大容量非経口薬（LVP）市場の成長を促進すると予想されます。ヘルスケア支出とは、ヘルスケアサービスや関連活動（健康研究や公衆衛生への取り組みを含む）に割り当てられる金額の増加を指します。ヘルスケア支出の増加は、新しい病院、診療所、医療施設の建設など、ヘルスケア・インフラの開発と拡張につながることが多いです。インフラの向上は医療サービスの提供能力を高め、LVPソリューションの需要を増大させる。例えば、2022年、英国の国家統計機関であるOffice for National Statisticsは、英国のヘルスケア支出が約3,548億8,000万米ドル（2,830億英ポンド）に達し、2021年比で名目0.7％の増加を反映したと報告しました。このように、ヘルスケア支出の増加が大容量非経口薬市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の大容量非経口薬（LVP） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の大容量非経口薬（LVP）市場：成長率分析
• 世界の大容量非経口薬（LVP）市場の実績：規模と成長, 2019-2024
• 世界の大容量非経口薬（LVP）市場の予測：規模と成長, 2024-2029, 2034F
• 世界の大容量非経口薬（LVP）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の大容量非経口薬（LVP）市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ソフトバッグ LVP
• ビニール袋LVP
• ガラスボトルLVP
• 世界の大容量非経口薬（LVP）市場：数量別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 100ML-250ML
• 250ML-500ML
• 500ML-1000ML
• 1000ML-2000ML
• 2000年以降
• 世界の大容量非経口薬（LVP）市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 基本的な注入
• 治療薬の注入
• 栄養たっぷりの注入
• 世界の大容量非経口薬（LVP）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 医療センター
• その他のエンドユーザー
• 世界の大容量非経口薬（LVP）市場、タイプ別サブセグメンテーション：ソフトバッグLVP、実績と予測, 2019-2024, 2024-2029F, 2034F
• PVCソフトバッグ
• 非PVCソフトバッグ
• 世界の大容量非経口薬（LVP）市場、タイプ別サブセグメンテーション：プラスチックバッグLVP、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリプロピレンバッグ
• ポリエチレン袋
• 世界の大容量非経口薬（LVP）市場、タイプ別サブセグメンテーション：ガラス瓶LVP、実績と予測, 2019-2024, 2024-2029F, 2034F
• 使い捨てガラスボトル
• 多用量ガラスボトル

第7章 地域別・国別分析

• 世界の大容量非経口薬（LVP）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の大容量非経口薬（LVP）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 大容量非経口薬（LVP）市場：競合情勢
• 大容量非経口薬（LVP）市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Otsuka Holdings Co Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Baxter International Inc.
• B Braun Melsungen AG
• Grifols SA
• Cipla Limited
• ICU Medical Inc.
• Biocon Limited
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Alembic Pharmaceuticals Limited
• Cadila Healthcare Ltd.
• Gland Pharma Limited
• Akums Drugs & Pharmaceuticals Ltd.
• Beximco Pharmaceutical Ltd.
• Nelson Laboratories LLC
• Taj Pharmaceuticals Limited
• Albert David Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 大容量非経口薬（LVP）市場2029：新たな機会を提供する国
• 大容量非経口薬（LVP）市場2029：新たな機会を提供するセグメント
• 大容量非経口薬（LVP）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Large Volume Parenteral (LVP) pertains to sterile intravenous solutions with a volume of 100 ml or more, undergoing terminal sterilization through heat. These solutions play a crucial role in intravenous infusions, facilitating the administration of hydration, nourishment, and medications.

The primary types of Large Volume Parenteral (LVP) include soft bag LVP, plastic bag LVP, and glass bottle LVP. Soft bag LVP involves the use of flexible bags containing sterilized intravenous solutions, employed in medical settings to deliver fluids and medications to patients. The varying volumes, ranging from 100 ml to 2000 ml and beyond, cater to different infusion needs, such as basic infusion, therapeutic infusion, and nutritious infusion. End-users of LVP include hospitals, medical centers, and other healthcare facilities.

The large volume parenteral (LVP) market research report is one of a series of new reports from The Business Research Company that provides large volume parenteral (LVP) market statistics, including large volume parenteral (LVP) industry global market size, regional shares, competitors with a large volume parenteral (LVP) market share, detailed large volume parenteral (LVP) market segments, market trends and opportunities, and any further data you may need to thrive in the large volume parenteral (LVP) industry. This large volume parenteral (LVP) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The large volume parenteral (LVP) market size has grown strongly in recent years. It will grow from $12.52 billion in 2024 to $13.57 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, growth in the aging population, rising demand for sterile pharmaceuticals, expansion of healthcare infrastructure, and development of regulatory frameworks for pharmaceuticals

The large volume parenteral (LVP) market size is expected to see strong growth in the next few years. It will grow to $19.46 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to growing demand for biologics and biosimilars, rising healthcare expenditure, expansion of pharmaceutical outsourcing, increasing focus on personalized medicine, and globalization of pharmaceutical supply chains. Major trends in the forecast period include technological advancements in manufacturing processes, integration of advanced technologies in pharmaceutical production, implementation of single-use technologies, development of high-concentration formulations, and rise in 3d printing applications for pharmaceuticals.

The increasing prevalence of chronic diseases is expected to drive the growth of the large-volume parenteral market in the coming years. Chronic diseases are defined as illnesses or conditions that typically persist for three months or longer and can worsen over time. The rise in chronic diseases is largely attributed to factors such as tobacco use, exposure to secondhand smoke, and poor nutrition. Patients with chronic conditions often require a precise balance of essential nutrients to maintain their strength, and parenteral administration allows for the accurate delivery of pharmaceutical dosages, as most of the drug is directly absorbed into circulation, bypassing the digestive system. For example, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that there are 41 million deaths annually worldwide, representing 74% of fatalities caused by non-communicable diseases (NCDs) or chronic diseases. Therefore, the growing prevalence of chronic diseases is driving the expansion of the large-volume parenteral market.

The rising healthcare expenditure is expected to drive the growth of the large-volume parenteral (LVP) market in the future. Healthcare expenditure refers to the increasing amount of money allocated for healthcare services and related activities, including health research and public health initiatives. Higher healthcare spending is often linked to the development and expansion of healthcare infrastructure, such as the construction of new hospitals, clinics, and healthcare facilities. Improved infrastructure enhances the capacity to deliver medical services, thereby increasing the demand for LVP solutions. For example, in 2022, the Office for National Statistics, a UK-based national statistics organization, reported that healthcare expenditure in the UK reached approximately $354.88 billion (£283 billion), reflecting a nominal increase of 0.7% compared to 2021. Thus, the increasing healthcare expenditure is driving the growth of the large-volume parenteral market.

Product innovation is a prominent and popular trend in the large-volume parenteral market, with major players dedicating efforts to the creation of innovative products to enhance their market positions. An illustrative example of this trend is observed with SGD Pharma SA, a France-based producer of molded and tubular glass for pharmaceutical primary packaging. In March 2022, SGD Pharma launched 100-ml type I molded glass vials that are sterile and ready for aseptic filling and finishing of parenteral medicinal formulations. These vials serve to prevent scratches, facilitate the visual examination of filled vials, and reduce the likelihood of rejection during quality control processes. This product innovation aligns with the market's focus on enhancing the quality and efficiency of large-volume parenteral products.

Major players in the market are strategically focusing on the development of innovative formulations to bolster their market position. The creation of innovative formulations plays a pivotal role in driving the success and growth of the large volume parenteral market. These formulations address clinical challenges, enhance patient outcomes, and adapt to the dynamic landscape of healthcare. For instance, in November 2022, WuXi AppTec, a leading pharmaceutical development and manufacturing company based in China, launched a Parenteral Formulation Manufacturing Line in Wuxi City. This new line features an integrated 15 m3 lyophilizer housed in a completely enclosed isolator, along with a fully automated vial loading and unloading system. The filling line accommodates vials for solutions and lyophilized powder in various sizes, enabling quick mode transitions and significantly accelerating large-volume parenteral drug product production speed at 200 vials per minute. The facility boasts an innovative filling machine and a state-of-the-art containment system, aligning with global cGMP requirements.

In March 2022, Fresenius Kabi, a healthcare company based in Germany, made a strategic move by acquiring Ivenix Inc. for $240 million. This acquisition aims to broaden Fresenius Kabi's access to infusion systems in hospitals, complementing its intravenous fluids and infusion treatment offerings, and reinforcing its position in the US market. Ivenix Inc., a US-based medical technology company, specializes in the development of the Ivenix Large Volume Pump (LVP). This strategic acquisition further strengthens Fresenius Kabi's capabilities in the large volume parenteral market.

Major companies operating in the large volume parenteral (LVP) market include Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Becton Dickinson and Company, Otsuka Holdings Co Ltd., Baxter International Inc., B Braun Melsungen AG, Grifols SA, Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Nelson Laboratories LLC, Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd, Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd, Pentagon Labs Ltd., DJ Labs Pvt Ltd., Higgs Healthcare.

North America was the largest region in the large volume parenteral (LVP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the large volume parenteral (lvp) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The large-volume parenteral (LVP) market consists of sales of sterile intravenous solutions, peritoneal dialysis solutions, plasma substitutes, and sterile powders. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Large Volume Parenteral (LVP) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on large volume parenteral (lvp) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for large volume parenteral (lvp) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The large volume parenteral (lvp) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Soft Bag LVP; Plastic Bag LVP; Glass Bottle LVP
• 2) By Volume: 100 ML - 250 ML; 250 ML - 500 ML; 500 ML - 1000 ML; 1000 ML -2000 ML; 2000 And More
• 3) By Application: Basic Infusion; Therapeutics Infusion; Nutritious Infusion
• 4) By End-User: Hospital; Medical Centers; Other End Users
• Subsegments:
• 1) By Soft Bag LVP: PVC Soft Bags; Non-PVC Soft Bags
• 2) By Plastic Bag LVP: Polypropylene Bags; Polyethylene Bags
• 3) By Glass Bottle LVP: Single-Use Glass Bottles; Multi-Dose Glass Bottles
• Companies Mentioned: Pfizer Inc.; Fresenius Kabi AG; Abbott Laboratories Inc.; Becton Dickinson and Company; Otsuka Holdings Co Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Large Volume Parenteral (LVP) Market Characteristics

3. Large Volume Parenteral (LVP) Market Trends And Strategies

4. Large Volume Parenteral (LVP) Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Large Volume Parenteral (LVP) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Large Volume Parenteral (LVP) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Large Volume Parenteral (LVP) Market Growth Rate Analysis
• 5.4. Global Large Volume Parenteral (LVP) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Large Volume Parenteral (LVP) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Large Volume Parenteral (LVP) Total Addressable Market (TAM)

6. Large Volume Parenteral (LVP) Market Segmentation

• 6.1. Global Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Soft Bag LVP
• Plastic Bag LVP
• Glass Bottle LVP
• 6.2. Global Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 100 ML - 250 ML
• 250 ML - 500 ML
• 500 ML - 1000 ML
• 1000 ML -2000 ML
• 2000 And More
• 6.3. Global Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Basic Infusion
• Therapeutics Infusion
• Nutritious Infusion
• 6.4. Global Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Medical Centers
• Other End Users
• 6.5. Global Large Volume Parenteral (LVP) Market, Sub-Segmentation Of Soft Bag LVP, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PVC Soft Bags
• Non-PVC Soft Bags
• 6.6. Global Large Volume Parenteral (LVP) Market, Sub-Segmentation Of Plastic Bag LVP, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polypropylene Bags
• Polyethylene Bags
• 6.7. Global Large Volume Parenteral (LVP) Market, Sub-Segmentation Of Glass Bottle LVP, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Glass Bottles
• Multi-Dose Glass Bottles

7. Large Volume Parenteral (LVP) Market Regional And Country Analysis

• 7.1. Global Large Volume Parenteral (LVP) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Large Volume Parenteral (LVP) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Large Volume Parenteral (LVP) Market

• 8.1. Asia-Pacific Large Volume Parenteral (LVP) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Large Volume Parenteral (LVP) Market

• 9.1. China Large Volume Parenteral (LVP) Market Overview
• 9.2. China Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Large Volume Parenteral (LVP) Market

• 10.1. India Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Large Volume Parenteral (LVP) Market

• 11.1. Japan Large Volume Parenteral (LVP) Market Overview
• 11.2. Japan Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Large Volume Parenteral (LVP) Market

• 12.1. Australia Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Large Volume Parenteral (LVP) Market

• 13.1. Indonesia Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Large Volume Parenteral (LVP) Market

• 14.1. South Korea Large Volume Parenteral (LVP) Market Overview
• 14.2. South Korea Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Large Volume Parenteral (LVP) Market

• 15.1. Western Europe Large Volume Parenteral (LVP) Market Overview
• 15.2. Western Europe Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Large Volume Parenteral (LVP) Market

• 16.1. UK Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Large Volume Parenteral (LVP) Market

• 17.1. Germany Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Large Volume Parenteral (LVP) Market

• 18.1. France Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Large Volume Parenteral (LVP) Market

• 19.1. Italy Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Large Volume Parenteral (LVP) Market

• 20.1. Spain Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Large Volume Parenteral (LVP) Market

• 21.1. Eastern Europe Large Volume Parenteral (LVP) Market Overview
• 21.2. Eastern Europe Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Large Volume Parenteral (LVP) Market

• 22.1. Russia Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Large Volume Parenteral (LVP) Market

• 23.1. North America Large Volume Parenteral (LVP) Market Overview
• 23.2. North America Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Large Volume Parenteral (LVP) Market

• 24.1. USA Large Volume Parenteral (LVP) Market Overview
• 24.2. USA Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Large Volume Parenteral (LVP) Market

• 25.1. Canada Large Volume Parenteral (LVP) Market Overview
• 25.2. Canada Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Large Volume Parenteral (LVP) Market

• 26.1. South America Large Volume Parenteral (LVP) Market Overview
• 26.2. South America Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Large Volume Parenteral (LVP) Market

• 27.1. Brazil Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Large Volume Parenteral (LVP) Market

• 28.1. Middle East Large Volume Parenteral (LVP) Market Overview
• 28.2. Middle East Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Large Volume Parenteral (LVP) Market

• 29.1. Africa Large Volume Parenteral (LVP) Market Overview
• 29.2. Africa Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Large Volume Parenteral (LVP) Market Competitive Landscape And Company Profiles

• 30.1. Large Volume Parenteral (LVP) Market Competitive Landscape
• 30.2. Large Volume Parenteral (LVP) Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Otsuka Holdings Co Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Large Volume Parenteral (LVP) Market Other Major And Innovative Companies

• 31.1. Baxter International Inc.
• 31.2. B Braun Melsungen AG
• 31.3. Grifols SA
• 31.4. Cipla Limited
• 31.5. ICU Medical Inc.
• 31.6. Biocon Limited
• 31.7. Sichuan Kelun Pharmaceutical Co. Ltd.
• 31.8. Alembic Pharmaceuticals Limited
• 31.9. Cadila Healthcare Ltd.
• 31.10. Gland Pharma Limited
• 31.11. Akums Drugs & Pharmaceuticals Ltd.
• 31.12. Beximco Pharmaceutical Ltd.
• 31.13. Nelson Laboratories LLC
• 31.14. Taj Pharmaceuticals Limited
• 31.15. Albert David Ltd.

32. Global Large Volume Parenteral (LVP) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Large Volume Parenteral (LVP) Market

34. Recent Developments In The Large Volume Parenteral (LVP) Market

35. Large Volume Parenteral (LVP) Market High Potential Countries, Segments and Strategies

• 35.1 Large Volume Parenteral (LVP) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Large Volume Parenteral (LVP) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Large Volume Parenteral (LVP) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer